Loading clinical trials...
Loading clinical trials...
Observational Retrospective Multicenter Study Aimed at Evaluating the Incidence of Hepatitis B Reactivation in Patients Affected by Chronic Lymphocytic Leukemia Treated With Ibrutinib
Conditions
Interventions
Lamivudine
No prophylaxis
Locations
23
Italy
AOU Arcispedale S.Anna - UOC Ematologia e fisiopatologia della coagulazione
Cona, Ferrara, Italy
AOU Consorziale Policlinico - UO Ematologia con Trapianto
Bari, Italy
ASST degli Ospedali Civili di Brescia - UO Ematologia
Brescia, Italy
AO Brotzu, Presidio Ospedaliero A.Businco - SC Ematologia e CTMO
Cagliari, Italy
CTC U.O. di Ematologia con Trapianto di midollo osseo - Catania
Catania, Italy
AO di Catanzaro "Pugliese - Ciaccio", Presidio Ospedaliero "Ciaccio - De Lellis" - Ematologia
Catanzaro, Italy
Start Date
November 28, 2018
Primary Completion Date
March 26, 2021
Completion Date
June 30, 2021
Last Updated
May 12, 2022
NCT07277231
NCT05006716
NCT06859424
NCT01804686
NCT05254743
NCT05371808
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions